Scientists used a new approach to identify a promising therapeutic target for glioblastoma, which was previously overlooked in traditional approaches.
Northwestern Medicine scientists have identified the unique targets of two enzymes that activate ubiquitination, a key modification of proteins that controls a variety of cellular processes.
An article published in JAMA recommends new updates to the red blood cell transfusion guidelines by the American Association of Blood Banks.
Northwestern Medicine scientists have demonstrated an enhanced approach to targeting a type of inflammatory cell involved in atherosclerosis.
A pair of proteins that promote blood vessel formation are associated with the development of severe malaria, and they may be a target for future therapeutics, according to recent research.
Kathleen Green, PhD, Joseph L. Mayberry, Sr., Professor of Pathology and Toxicology and professor of Dermatology, has been elected to the German National Academy of Sciences for her scientific achievements.